3、转移性前列腺癌 Regional prostate cancer (Any T, Any N, M1) 普遍治疗原则同Regional prostate cancer
NCCN NCCN clinical practice guidelines in oncology (2007) prostate cancer early detection. Version 2. Accessed at http://www.nccn.org/professionals/ physician_gls/PDF/prostate.pdfProstate cancer early detection. Practice guidelines in oncology . NCC Network . 2007. Published online by NCCN. http:...
antiandrogen, if none had been administered previously. Patients refractory to further hormonal manipulations are observed or receive palliative therapy, including chemotherapy. The treatment of prostate cancer is complex. Optimal treatment is risk-adapted to the specific characteristics of the cancer ...
National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Accessed January 7, 2020. https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf 11. Department of Veterans Affairs. About VHA. Accessed January 7, 2020. https://www.va.gov/health/aboutvha.asp 12. Ch...
https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf 3. Rice MA, Malhotra SV, Stoyanova T. Second-generation antiandrogens: from discovery to standard of care in castration resistant prostate cancer. Front Oncol. 2019;9:801. doi:10.3389/fonc.2019.00801 PubMed...
The NCCN Prostate Cancer Panel also added new indications for existing agents, including the option of sipuleucel-T as second-line therapy. In addition, brachytherapy in combination with external beam radiation therapy with or without androgen deprivation therapy is now an alternative for patients with...
NCCN Guidelinesand this illustration may not be reproduced in any form without the express written permission of NCCN. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines?) Prostate Cancer Version 2.2021 — February 17, 2021 NCCN.org NCCN Guidelines for Patients? available at /patients ...
Keywords included “prostate cancer”, “nonmetastatic”, “castration-resistance”, “rising PSA”, “biochemical relapse”. The latest versions of the European Society for Medical Oncology, National Comprehensive Cancer Network (NCCN), European Association of Urology, Prostate Cancer Radiographic ...
The National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Prostate Cancer (v1.2020) recommend CT or magnetic resonance imaging (MRI) for staging with the addition of conventional bone scans for the detection of metastases [4]. Next-generation techniques, such as positron ...
Metastatic biopsy programmes combined with advances in genomic sequencing have provided new insights into the molecular landscape of castration-resistant prostate cancer (CRPC), identifying actionable targets, and emerging resistance mechanisms. The detection of DNA repair aberrations, such as mutation of ...